A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
Subscribe to Continue Reading
Uh oh–you've read all of your free articles for this month.
A DNA App Store Is Here, but Proceed with Caution
Helix will sequence your genes for $80 and lure app developers to sell you access to different parts of it.
The Emerging Science of Computational Psychiatry
Machine learning, data mining, and artificial intelligence are revolutionizing the study and understanding of mental illness.
3-D-Printed Artificial Heart Beats Like the Real Thing But Isn’t Much Use Yet
It pumps blood using ventricles like those of a real heart, but it begins to degrade after just 3,000 beats.